Serological assay for coronavirus 2019 (COV-ID-19) patients including asymptomatic cases can inform on disease progression and prognosis. A detection method taking into account multiplex, high sensitivity, and a wider detection range will help to identify and treat COVID-19. Here we integrated color-size dualencoded beads and rolling circle amplification (RCA) into a bead-based fluorescence immunoassay implemented in a size sorting chip to achieve high-throughput and sensitive detection. We used the assay for quantifying COVID-19 antibodies against spike S1, nucleocapsid, the receptor binding domain antigens. It also detected inflammatory biomarkers including interleukin-6, interleukin-1β, procalcitonin, C-reactive protein whose concentrations range from pg mL À 1 to μg mL À 1 . Use of different size beads integrating with RCA results in a tunable detection range. The assay can be readily modified to simultaneously measure more COVID-19 serological molecules differing by orders of magnitude.Coronavirus 2019 (COVID-19) caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented worldwide pandemic. Serological immunoglobulins and pro-inflammatory cytokines induced by SARS-CoV-2 were observed both in symptomatic patients and some asymptomatic cases. [1] Circulating antibodies specific to SARS-COV-2 and inflammatory biomarkers not only provide evidence for diagnosing a SARS-COV-2 infection and predicting protective immunity but